课题基金 / 基金详情

Cellular Immunity Against Ehrlichia chaffeensis

Cellular Immunity Against Ehrlichia chaffeensis
针对恰菲埃里希体的细胞免疫
批准号:
7169913
负责人:
ROMAN R. GANTA
金额:
$34.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2009-01-31
关键词:
AddressAdoptive TransferAffectAnaplasmaAnaplasma phagocytophilumAnaplasmataceaeAnimalsAntibodiesAntigen Presentation PathwayAntigensAppendixAscitesB-LymphocytesBasic ScienceBiological ModelsCD4 Positive T LymphocytesCD8B1 geneCHRM5 geneCanis familiarisCase StudyCell surfaceCellsCellular ImmunityCoyotesCytolysisCytotoxic T-LymphocytesDNA VaccinesDataData ReportingDeerDevelopmentDiseaseEhrlichiaEhrlichia chaffeensisEhrlichia ruminantiumEhrlichiosisElderlyEventFamilyFutureGene ActivationGenesGeneticGenus CapraGoalsGoatGram-Negative BacteriaGranulomaHealthHeartwater DiseaseHelper-Inducer T-LymphocyteHost DefenseHost resistanceHumanImmuneImmune responseImmune systemImmunityImmunocompetentImmunocompromised HostImmunoglobulin GIn VitroIncidenceIndividualInfectionInterferon Type IIInterferonsInterventionInvestigationJanus kinaseKnock-outLaboratoriesLeadLifeLimesLiteratureMacrophage ActivationMapsMeasuresMediatingMembrane Protein GeneMembrane ProteinsModelingMolecularMonitorMonoclonal AntibodiesMorulaMouse StrainsMusMutationNamesNomenclatureNumbersOrganismPathway interactionsPerformancePhagocytesPhagosomesPhylogenyPlasma CellsPrincipal InvestigatorProceduresProcessProteinsPublic HealthPublicationsRateReportingResearchResearch PersonnelRickettsiaRickettsialesRiskRuminantsSCID MiceSTAT proteinSplenic TissueSymptomsSystemT-LymphocyteTailTestingTicksTyrosine PhosphorylationVaccine DesignVaccinesVertebratesWorkbasecell typecytokinedayhuman datahuman diseasehuman granulocytic ehrlichiosisimmunogenicinsightmacrophagemolecular arraymonocytemortalitymouse modelpathogenprogramsrRNA Genesresearch studyresponsesizetoolvaccine development

项目摘要

项目成果

ROMAN R. GANTA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Human ehrlichiosis is caused by three agents including Ehrlichia chaffeensis, Anaplasma phagocytophila and by E. ewengii. These potentially fatal infections pose a serious threat to public health, particularly to immunocompromised and elderly people. However, little is known about the mechanisms of host resistance and reasons for the emergence of these diseases. This project proposes to characterize the host immune response necessary for clearance using mouse as the experimental host because the course of E. chaffeensis infection is similar between immunocompetent humans and mice and the model will provide data for human applications. Moreover, the extensive array of molecular, immunological and genetic tools available for mice will allow us to manipulate the system in ways that are not possible in other species. Specifically, three hypotheses will be tested: 1)TH1 type helper T-cells are required for clearance of E. chaffeensis; 2) Secreted cytokines from T-cells are needed for host resistance to E. chaffeensis infections; 3) Macrophage activation contributes to the clearance of E. chaffeensis. Several observations form the basis for this project: immunocompetent mice clear E. chaffeensis by 16 days and the clearance is associated with the expression of an E. chaffeensis-specific TH1 type IgG response, CTL response and granuloma formation; the infections are fatal in SCID mice lacking T- and B-cells; mice lacking functional MHCII genes establish long-term persistent infections after E. chaffeensis challenge; mice deficient for macrophage activation develop short-term persistent infections; and prior activation with IFN-gamma inhibits monocyte infections with E. chaffeensis. The importance of helper T-cells, cytotoxic T-cells, B-cell responses, cytokines, and macrophage activation will be evaluated using several mouse strains with different genetic backgrounds and by manipulating their immune systems to diminish or enhance particular immune components. Infections will be monitored using bacteriological, molecular, immunological, and pathological analyses to assess host immunity and infection status. The long-term goals of this project are to elucidate host immune mechanisms, pathogen evasion strategies and to ultimately use the information to devise effective intervention measures against E. chaffeensis and other closely related organisms.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Rocky Mountain Spotted Fever Vaccine Development
  • 批准号:
    10477183
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    ROMAN R. GANTA
  • 依托单位:
Rocky Mountain Spotted Fever Vaccine Development
  • 批准号:
    10675538
  • 项目类别:
  • 资助金额:
    $71.9万
  • 财政年份:
    2021
  • 负责人:
    ROMAN R. GANTA
  • 依托单位:
Rocky Mountain Spotted Fever Vaccine Development
  • 批准号:
    9998279
  • 项目类别:
  • 资助金额:
    $76.0万
  • 财政年份:
    2021
  • 负责人:
    ROMAN R. GANTA
  • 依托单位:
Rocky Mountain Spotted Fever Vaccine Development
  • 批准号:
    10814647
  • 项目类别:
  • 资助金额:
    $75.61万
  • 财政年份:
    2021
  • 负责人:
    ROMAN R. GANTA
  • 依托单位:
海外基金